TNF Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
TNF Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2013 to Q2 2024.
  • TNF Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $12.5M, a 8.64% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $12.5M +$997K +8.64% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $1.51M -$13.9M -90.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.24M -$1.84M -45.1% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $8.17M +$1.4M +20.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $11.5M +$7.03M +156% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $15.4M +$7.36M +92% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $4.09M -$6.92M -62.9% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $6.77M -$7.23M -51.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $4.51M -$15M -76.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $8M -$22.5M -73.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $11M -$5.72M -34.2% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $14M +$7.07M +102% Sep 30, 2021 10-Q/A 2021-11-15
Q2 2021 $19.5M +$12.6M +184% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $30.5M +$23.9M +360% Mar 31, 2021 10-Q 2021-05-18
Q4 2020 $16.7M +$7.55M +82.4% Dec 31, 2020 10-Q 2021-05-18
Q3 2020 $6.93M +$4.08M +144% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $6.86M +$2.84M +70.5% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $6.63M +$2.15M +48.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $9.16M +$3.89M +73.8% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.85M -$2.02M -41.5% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $4.02M -$3.96M -49.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $4.48M -$4.2M -48.4% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $5.27M +$261K +5.22% Dec 31, 2018 10-K 2020-03-25
Q3 2018 $4.87M +$4.86M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $7.98M +$6.97M +689% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $8.68M +$8.52M +5411% Mar 31, 2018 10-Q 2018-07-13
Q4 2017 $5.01M +$4.96M +9923% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $10.2K* -$590K Sep 30, 2017 10-Q/A 2018-07-13
Q2 2017 $1.01M -$536K -34.7% Jun 30, 2017 10-Q/A 2018-07-13
Q1 2017 $157K -$2.28M -93.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $50K -$3.98M -98.8% Dec 31, 2016 10-K/A 2018-07-13
Q3 2016 $600K -$4.63M -88.5% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $1.55M -$4.87M -75.9% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $2.44M -$5.62M -69.7% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $4.03M -$5.24M -56.6% Dec 31, 2015 10-K 2017-04-11
Q3 2015 $5.23M -$4.98M -48.8% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $6.42M -$5.03M -43.9% Jun 30, 2015 10-Q 2015-08-18
Q1 2015 $8.06M -$4.44M -35.5% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $9.26M +$9.26M Dec 31, 2014 10-K 2016-03-30
Q3 2014 $10.2M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $11.4M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $12.5M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $0 Dec 31, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.